Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Sarcoma 2Plasma cell 2Other solid neoplasm 2CNS 2Thoracic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Mesothelioma, Malignant 4Colonic Neoplasms 4Carcinoma, Ovarian Epithelial 4Carcinoma, Renal Cell 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Neoplasm Metastasis 2Mesothelioma 2Melanoma 2Kidney Neoplasms 2Endometrial Neoplasms 2Carcinoma, Hepatocellular 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1

Interventions

sargramostim 1oblimersen 1entinostat 1atezolizumab 1Ritonavir 1Radiotherapy 1Platinum 1Nivolumab 1Indinavir 1Granulocyte-Macrophage Colony-Stimulating Factor 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × sargramostim × Thoracic × Clear all
NCT04040231 2025-05-13

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡